Figure 21.1
Spectra of narrow‐band UVB (NB‐UVB), broad‐band UVA (BB‐UVA) and UVA‐1. PUVA, psoralen and UVA.
Figure 21.5
Psoriasis affecting a patient's back (a) before and (b) after narrow‐band (TL‐01) UVB therapy showing the effectiveness of the treatment. (Reproduced...
Figure 21.9
Patient with psoriasis receiving narrow‐band UVB in a whole body cabinet.
Figure 21.13
Flare of polymorphic light eruption on the chest induced by UVB therapy.
Figure 21.2
Whole body narrow‐band UVB cabinet.
Figure 21.6
Atopic eczema affecting a patient's legs (a) before and (b) after narrow‐band UVB therapy.
Figure 21.10
Patient's hands being irradiated with UVA following a topical psoralen soak.
Figure 21.14
PUVA lentigines affecting a patient's legs.
Figure 21.3
Narrow‐band UVB unit for the treatment of hands and feet.
Figure 21.7
Narrow‐band UVB minimal erythema dose (MED) reading 24 h after the irradiation of phototest sites. Doses are in mJ/cm 2 .
Figure 21.11
(a) Patient receiving extracorporeal photopheresis. (b) Close up of the upper part of photopheresis equipment showing the patient's buffy coat contain...
Figure 21.15
UVB referral form.
Figure 21.4
Irradiance of UV tubes being measured by a radiometer clamped in position at a fixed distance.
Figure 21.8
Hand‐held Hybec ‘Durham’ phototesting unit.
Figure 21.12
Burn sustained to the lower trunk during narrow‐band UVB therapy due to slipping of the patient's underpants.
